Chai Discovery
AI-driven drug discovery and design
CORE INFO
Chai Discovery is a pioneering biotechnology company that leverages artificial intelligence to transform the field of drug discovery. By focusing on the design of novel molecules, particularly antibodies, Chai Discovery aims to revolutionize therapeutic development. Their advanced AI models are capable of predicting and reprogramming interactions between biochemical molecules, effectively turning biology from a traditional science into a more precise engineering discipline. Founded in 2024 and headquartered in San Francisco, California, Chai Discovery has made significant strides in the biotech and pharmaceutical industries. The company has developed AI models such as Chai-1 and Chai-2, which are instrumental in predicting molecular structures and designing de novo antibodies. These innovations have led to notable achievements, including a near-20% hit rate in antibody design, which marks a substantial improvement over existing methods. With a mission to accelerate the development of life-changing therapeutics, Chai Discovery continues to advance AI-driven solutions in drug discovery.
WHY WE WOULD WORK AT CHAI DISCOVERY
Innovative AI Models
Work with cutting-edge AI models like Chai-1 and Chai-2, revolutionizing molecular structure prediction and antibody design.
Rapid Growth Potential
Join a Series B funded company valued at $1.3 billion, offering significant opportunities for career advancement and impact.
Pioneering Drug Discovery
Contribute to transforming biology into an engineering discipline, accelerating the development of life-changing therapeutics.
Collaborative Team Culture
Be part of a dynamic team of 51 experts, fostering innovation and collaboration in the heart of San Francisco.
Recognized Achievements
Participate in a company with notable achievements, including a near-20% hit rate in de novo antibody design.
Competitive Compensation
Benefit from substantial funding and resources, ensuring competitive salaries and benefits for top talent.
MARKET AND TRACTION
GROWTH TACTICS
KEY METRICS
✦ KEY METRICCOMPETITIVE ADVANTAGE
MARKET POSITION
PRODUCT AND TECH
Chai-1 AI Model
Chai-1 is an open-source foundation model designed for predicting molecular structures. It plays a crucial role in transforming biology into a precise engineering discipline by enhancing the accuracy of molecular predictions.
Chai-2 Antibody Design
Chai-2 is an advanced AI model that achieves near-20% hit rates in de novo antibody design. This innovation significantly improves the efficiency of therapeutic development compared to traditional methods.
AI-Driven Drug Discovery
Chai Discovery leverages artificial intelligence to revolutionize drug discovery by designing novel molecules with therapeutic potential. This approach accelerates the development of life-changing therapeutics by reprogramming biochemical interactions.
Biochemical Interaction Reprogramming
The company's AI models predict and reprogram interactions between biochemical molecules. This technology transforms biology from a traditional science into a more precise engineering discipline, enhancing drug discovery processes.